← Leaderboards
Donald J Abraham
Virginia Commonwealth University
$2,339,333
Attributed
$2,339,333
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $307.5K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$2,339,333 · 4
By mechanism
R01$2,227,262 · 3
R42$112,071 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Cynthia Nau Cornelissen$16,417,118
- Gordon D Ginder$21,192,432
- Martin K Safo$4,719,250
- Roland N Pittman$6,266,571
- Wally R Smith$9,055,907
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionX Ray CrystallographyAllosteric SiteProtein Structure FunctionClinical ResearchEnzyme StructureIsozymesPyruvate KinaseDrug Screening /EvaluationMolecular CloningEnzyme MechanismEnzyme InhibitorsTissue /Cell CultureFluorescent Dye /ProbeHuman SubjectElectrophoresisDrug Discovery /IsolationHemoglobin AsChemical SynthesisChemical KineticsHemoglobinHeart /Lung BypassDogsEstrogen Receptors
Grant awards (8)
Rational Design of Novel Estrogen Receptor Antagonists$300,275
R01 · FY2006 · CA · contact PI
Rational Design of Novel Estrogen Receptor Antagonists$307,500
R01 · FY2005 · CA
Design &Development of Allosteric effectors of PK$337,500
R01 · FY2004 · HL
Rational Design of Novel Estrogen Receptor Antagonists$296,020
R01 · FY2004 · CA
Design &Development of Allosteric effectors of PK$337,500
R01 · FY2003 · HL
Design &Development of Allosteric effectors of PK$362,500
R01 · FY2002 · HL
DESIGN AND DEVELOPMENT OF POTENTIAL ANTISICKLING AGENTS$285,967
R01 · FY2000 · HL
DESIGN &DEVELOPMENT OF HEMOGLOBIN ALLOSTERIC EFFECTORS$112,071
R42 · FY2000 · HL